ABBOTT LABORATORIES Annual Net Cash Provided by (Used in) Financing Activities in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Abbott Laboratories quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from 2010 to 2023.
  • Abbott Laboratories Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was -$1.18B, a 16.6% increase year-over-year.
  • Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2023 was -$7.09B, a 7.14% increase from 2022.
  • Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2022 was -$7.64B, a 39% decline from 2021.
  • Abbott Laboratories annual Net Cash Provided by (Used in) Financing Activities for 2021 was -$5.49B, a 97.7% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 -$7.09B +$545M +7.14% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-16
2022 -$7.64B -$2.14B -39% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-16
2021 -$5.49B -$2.72B -97.7% Jan 1, 2021 Dec 31, 2021 10-K 2024-02-16
2020 -$2.78B +$1.51B +35.2% Jan 1, 2020 Dec 31, 2020 10-K 2023-02-17
2019 -$4.29B +$6.1B +58.7% Jan 1, 2019 Dec 31, 2019 10-K 2022-02-18
2018 -$10.4B -$5.11B -96.8% Jan 1, 2018 Dec 31, 2018 10-K 2021-02-19
2017 -$5.28B -$16.4B -147% Jan 1, 2017 Dec 31, 2017 10-K 2020-02-21
2016 $11.1B +$13.4B Jan 1, 2016 Dec 31, 2016 10-K 2019-02-22
2015 -$2.24B +$506M +18.5% Jan 1, 2015 Dec 31, 2015 10-K 2018-02-16
2014 -$2.74B +$3.95B +59.1% Jan 1, 2014 Dec 31, 2014 10-K 2017-02-17
2013 -$6.7B -$6.89B -3534% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-19
2012 $195M +$6.62B Jan 1, 2012 Dec 31, 2012 10-K 2015-02-27
2011 -$6.42B -$5.34B -490% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-21
2010 -$1.09B Jan 1, 2010 Dec 31, 2010 10-K 2011-02-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.